Skip to main content

Find Clinical Trials

Home
Conditions
Abemaciclib

Clinical trial condition

Abemaciclib

Explore clinical trials studying Abemaciclib. Study availability and eligibility vary by location and protocol.

6 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Abemaciclib trial results

Recruiting

Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

NCT07264998

Conditions: Abemaciclib, Abemaciclib-related Diarrhea, Breast Diseases, +9 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

NCT07190443

Conditions: Abemaciclib, Breast Cancer, Breast Diseases, +7 more
Locations: Cancer Institute Hospital of JFCR Koto-ku, Tokyo, Japan

View Trial Details

Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions: Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations: Centro di Riferimento Oncologico IRCCS Aviano, Italy

Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy

Humanitas Istituto Clinico Catanese Catania, Italy

ASST Lariana - Ospedale Sant'Anna Como, Italy

View all 24 locations

View Trial Details

Recruiting

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

NCT06621459

Conditions: Abemaciclib, Adjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols, +7 more
Locations: Chu Brest Brest, France

View Trial Details

Not Yet Recruiting

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

NCT07490509

Conditions: Abemaciclib, Abemaciclib-related Diarrhea, Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

NCT07443774

Conditions: Abemaciclib, Breast Cancer, Breast Diseases, +9 more
Locations: CHU Grenoble Alpes Grenoble, France

View Trial Details